---
title: "Kintor Pharma falls 6% in Hong Kong trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305900969.md"
description: "Kintor Pharma fell 6.21% to HK$1.360. Down 51.25% over six months and down 30.61% YTD."
datetime: "2026-11-18T02:13:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305900969.md)
  - [en](https://longbridge.com/en/news/305900969.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305900969.md)
generator: "portal-rs"
---

# Kintor Pharma falls 6% in Hong Kong trading

Kintor Pharma (9939.HK) fell more than **6%** in Hong Kong trading, last at **HK$1.360**.

The stock is down 51.25% over the past six months and down 30.61% year to date. It sits 71.06% below its 52-week high of HK$4.700.

The Hang Seng Index is down 3.82% over the past five sessions and down 8.75% year to date.

The biotechnology industry index fell 2.1% over the same period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [09939.HK](https://longbridge.com/en/quote/09939.HK.md)

## Related News & Research

- [Kintor net loss narrows 9% to RMB 75.8 million in 1H FY26; revenue rises to RMB 52 million](https://longbridge.com/en/news/296370818.md)
- [Kintor Pharma completes 52-week human safety trial of skin-whitening ingredient KT-939](https://longbridge.com/en/news/298141186.md)
- [GIGABYTE Concludes AI Partner Summit, Showcasing Real-World AI Agent Solutions for Enterprise](https://longbridge.com/en/news/306311368.md)
- [AI tech rout prompts US investors to rush into value stocks](https://longbridge.com/en/news/306321872.md)
- [Key facts: SK hynix results surge; Kioxia stake rises; HYAICO formed](https://longbridge.com/en/news/306338337.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**